Calcitonin Gene-Related Peptide Inhibition: The Advent of Biologics in Rosacea

Kaur, Gurnoor, Bhatt, Ria, Chow, Yan-Ching orcid iconORCID: 0009-0007-4891-8231, Siripanich, Chawalpat orcid iconORCID: 0009-0006-7848-8669 and Ali, Faisal orcid iconORCID: 0000-0002-8588-791X (2025) Calcitonin Gene-Related Peptide Inhibition: The Advent of Biologics in Rosacea. Clinical and Experimental Dermatology, 50 (11). pp. 2354-2355. ISSN 0307-6938

[thumbnail of VOR]
Preview
PDF (VOR) - Published Version
Available under License Creative Commons Attribution.

531kB

Official URL: https://doi.org/10.1093/ced%2Fllaf299

Abstract

Persistent facial erythema and flushing in rosacea remain challenging to treat with current therapies. A recent noteworthy open-label trial found that erenumab, a CGRP receptor inhibitor, significantly reduced moderate to extreme flushing and erythema in treatment-resistant patients, highlighting a novel neurovascular-targeted therapeutic approach.


Repository Staff Only: item control page